Investigative Ophthalmology & Visual Science Cover Image for Volume 62, Issue 8
June 2021
Volume 62, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2021
Early Nutritional Source and Retinopathy of Prematurity in Latin American Infants
Author Affiliations & Notes
  • Zesemayat Kidanu Mekonnen
    School of Medicine, University of California San Francisco, San Francisco, California, United States
  • Judith Espinoza Navarro
    Department of Ophthalmology, Hospitales Angeles, Mexico City, Mexico
  • Luz Consuelo Zepeda-Romero
    Hospital Civil “Fray Antonio Alcalde”, Universidad de Guadalajara Centro Universitario de Ciencias de la Salud, Guadalajara, Jalisco, Mexico
  • Maria Marta Galan
    Department of Ophthalmology, Hospital de Niños S. Ma. Ludovica de La Plata, La Plata, Argentina
  • Gil Binenbaum
    Department of Ophthalmology, University of Pennsylvania, Philadelphia, Pennsylvania, United States
  • Alejandra G. de Alba Campomanes
    Department of Ophthalmology, University of California San Francisco, San Francisco, California, United States
  • Footnotes
    Commercial Relationships   Zesemayat Mekonnen, None; Judith Navarro, None; Luz Zepeda-Romero, None; Maria Galan, None; Gil Binenbaum, None; Alejandra de Alba Campomanes, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science June 2021, Vol.62, 3243. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Zesemayat Kidanu Mekonnen, Judith Espinoza Navarro, Luz Consuelo Zepeda-Romero, Maria Marta Galan, Gil Binenbaum, Alejandra G. de Alba Campomanes; Early Nutritional Source and Retinopathy of Prematurity in Latin American Infants. Invest. Ophthalmol. Vis. Sci. 2021;62(8):3243.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Early nutritional status and nutritional source type has been reported to be associated with the prevention of retinopathy of prematurity (ROP) in high-income countries. We sought to determine if nutritional source within the first two weeks of life is associated with the development or regression of ROP in a Latin American cohort.

Methods : Secondary analysis of data from a prospective study of premature infants in La Plata, Argentina, and Guadalajara, Mexico between 2012-2014. Primary outcomes were the associations between the nutritional source in the first 2 weeks of life (predominantly total parental nutrition (TPN) or formula, or exclusive breastmilk) and presence, severity (treatment-requiring), and time to spontaneous regression of ROP or IGF-1 levels (ng/mL), adjusting for gestational age (GA) and birth weight (BW), using multivariable regression and ANOVA.

Results : One-hundred infants were studied, with mean (±SD) GA 31.3 (±2.7) weeks, median BW was 1395 g (range 620-2250), and 52% female. Most common nutritional source was predominantly TPN in postnatal weeks 1 (74%) and 2 (45%). Forty-three infants developed ROP, 19 were treated, while 21 children had documented full spontaneous regression at time of discharge. Median time to regression was 5 weeks (range 1-9 weeks). No associations were found between the nutritional source in the first 2 weeks of life and presence, severity, or time to spontaneous ROP regression and vascular maturation. No association was found between mean IGF-1 levels and ROP status by nutritional source.

Conclusions : We did not find an association between sources of nutrition during the 1st two weeks of life and ROP development, severity, or spontaneous ROP regression in this cohort of Latin American infants at risk for ROP.

This is a 2021 ARVO Annual Meeting abstract.

 

Figure 1. Mean weight gain (g) during postnatal week 1 (A) and postnatal week 2 (B) by nutritional source.

Figure 1. Mean weight gain (g) during postnatal week 1 (A) and postnatal week 2 (B) by nutritional source.

 

Figure 2. Mean IGF-1 levels (ng/mL) by nutritional source type during postnatal week 1 (A) and postnatal week 2 (B) and ROP severity.

Figure 2. Mean IGF-1 levels (ng/mL) by nutritional source type during postnatal week 1 (A) and postnatal week 2 (B) and ROP severity.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×